| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |